Withdrawal of Approval of New Animal Drug Applications; Phenylbutazone; Pyrantel; Tylosin; Sulfamethazine; Correction, 22713 [2011-9778]
Download as PDF
<![CDATA[
22713
Federal Register / Vol. 76, No. 78 / Friday, April 22, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Developmental Disabilities
Annual Protection and Advocacy
Systems Program Performance Report.
OMB No.: 0980–0160.
Description: This information
collection is required by Federal statute.
Each State Protection and Advocacy
System must prepare and submit a
program Performance Report for the
preceding fiscal year of activities and
accomplishments and of conditions in
the State. The information in the
Annual Report will be aggregated into a
national profile of Protection and
Advocacy Systems. It will also provide
the Administration on Developmental
Disabilities (ADD) with an overview of
program trends and achievements and
will enable ADD to respond to
administration and congressional
requests for specific information on
program activities. This information
will also be used to submit a Centennial
Report to Congress as well as to comply
with requirements in the Government
Performance and Results Act of 1993.
Respondents: Protection and
Advocacy Entities.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Program Performance Report .........................................................................
57
1
44
2,508
Estimated Total Annual Burden
Hours: 2,508.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
E-mail:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011–9772 Filed 4–21–11; 8:45 am]
mstockstill on DSKH9S0YB1PROD with NOTICES
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Health Resources and Services
Administration
[Docket No. FDA–2011–N–0033]
Withdrawal of Approval of New Animal
Drug Applications; Phenylbutazone;
Pyrantel; Tylosin; Sulfamethazine;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) published a
document in the Federal Register of
March 2, 2011 (76 FR 11490), providing
notice of the voluntary withdrawal of
approval of eight new animal drug
applications (NADAs). That document
contained an error in the preamble. FDA
is correcting the name and address for
the sponsor of five of the NADAs. This
correction is being made to improve the
accuracy of the Federal Register.
FOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary
Medicine (HFV–6), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9019,
e-mail: george.haibel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of March 2, 2011, in FR
Doc. 2011–4545, on page 11490, in the
first column, correct the Truow
Nutrition, Inc., name and address to
read: Trouw Nutrition USA LLC, P.O.
Box 219, 115 Executive Dr., Highland,
IL 62249.
SUMMARY:
Dated: April 15, 2011.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2011–9778 Filed 4–21–11; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
16:01 Apr 21, 2011
Jkt 223001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Administration for Children and
Families
Advisory Committee on the Maternal,
Infant and Early Childhood Home
Visiting Program Evaluation; Notice of
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C. appendix 2),
notice is hereby given of the following
meeting:
Name: Advisory Committee on the
Maternal, Infant and Early Childhood
Home Visiting (MIECHV) Program
Evaluation.
Date and Time: Thursday, May 5,
2011:
9 a.m.–5:15 p.m. EST. Friday, May 6,
2011:
9 a.m.–2:15 p.m. EST.
Place: Hilton Alexandria Old Town,
1767 King Street, Alexandria, Virginia
22314. (703) 837–0440.
This notice announces a forthcoming
meeting of a public advisory committee
of the Health Resources and Services
Administration and the Administration
for Children and Families. The meeting
will be open to the public. This notice
is being published less than 15 days
prior to the meeting due to difficulties
in securing adequate and accessible
space to accommodate the public.
Meeting Registration: To register for
the meeting, the public can contact
Carolyn Swaney at cswaney@icfi.com.
Agenda: The purpose of this meeting
is to gather comments from the
Committee on the design of the MIECHV
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 76, Number 78 (Friday, April 22, 2011)]
[Notices]
[Page 22713]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9778]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0033]
Withdrawal of Approval of New Animal Drug Applications;
Phenylbutazone; Pyrantel; Tylosin; Sulfamethazine; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) published a document in
the Federal Register of March 2, 2011 (76 FR 11490), providing notice
of the voluntary withdrawal of approval of eight new animal drug
applications (NADAs). That document contained an error in the preamble.
FDA is correcting the name and address for the sponsor of five of the
NADAs. This correction is being made to improve the accuracy of the
Federal Register.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail:
george.haibel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the Federal Register of March 2, 2011, in
FR Doc. 2011-4545, on page 11490, in the first column, correct the
Truow Nutrition, Inc., name and address to read: Trouw Nutrition USA
LLC, P.O. Box 219, 115 Executive Dr., Highland, IL 62249.
Dated: April 15, 2011.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2011-9778 Filed 4-21-11; 8:45 am]
BILLING CODE 4160-01-P
